股总动脉内膜切除术的发病率与死亡率
这项回顾性临床研究分析了129例孤立性股总动脉内膜切除术(CFE),术后6个月死亡率13%,局部并发症17%,全身并发症15%。高ASA分级独立预测6个月死亡率(OR 3.08,95%CI 1.03-9.24,P=.044)。作者认为CFE并非良性血管手术,未来发展的腔内方法可能有助于降低发病率与死亡率。
要点
- 129例CFE中,术后6个月死亡率13%,局部并发症17%,严重全身并发症15%。
- 局部并发症与肥胖显著相关(P=.002),与技术和手术因素无关。
- 高ASA分级独立预测6个月死亡率(OR 3.08,95%CI 1.03-9.24,P=.044)。
核心结论
- CFE虽然常被实施,但并非良性血管手术;疾病表现、麻醉风险和预期寿命对临床结局有重要作用。
- 作者认为,未来发展的股总动脉腔内方法可能有助于降低发病率与死亡率。
研究设计与样本
- 回顾性临床研究,连续纳入一家大型城市医院7年间实施的129例孤立性股总动脉内膜切除术(CFE)。
- 采用单因素和多因素分析评估6个月死亡率、局部并发症和全身并发症。
主要发现
- 手术指征为间歇性跛行36%、静息痛16%、组织缺损29%、慢加急性肢体缺血21%。
- 平均年龄75±9岁,68%为男性;合并症包括冠心病54%、糖尿病41%、慢性肺病25%、充血性心力衰竭22%。
- 98%的CFE在全身麻醉下进行,补片血管成形术使用牛心包73%vs涤纶27%。
- 22例(17%)发生局部并发症,与肥胖显著相关(P=.002),与技术和手术因素无关。
- 19例(15%)发生严重全身并发症,与慢性肢体威胁性缺血(P<.001)和高ASA分级(P=.002)显著相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Common femoral endarterectomy (CFE) comprises the current standard-of-care for symptomatic common femoral artery occlusive disease. Although it provides effective inflow revascularization via a single incision, it remains an invasive procedure in an often-frail patient population. The purpose of this retrospective clinical study was to assess the morbidity and mortality of CFE in a contemporary cohort. METHODS: Consecutive CFEs performed at a large, urban hospital were reviewed. Six-month mortality, local complications (hematoma, lymphatic leak, pseudoaneurysm, wound infection, and/or dehiscence), and systemic complications were analyzed using univariate and multivariate analyses. RESULTS: A total of 129 isolated CFEs were performed over 7 years for claudication (36%), rest pain (16%), tissue loss (29%), or acute on chronic limb ischemia (21%). Mean age was 75 ± 9 years, and 68% of patients were male. Comorbidities were prevalent, including coronary artery disease (54%), diabetes (41%), chronic pulmonary disease (25%), and congestive heart failure (22%). The majority of CFEs were performed under general anesthesia (98%) with patch angioplasty using bovine pericardium (73% vs 27% Dacron). Twenty-two patients (17%) sustained local complications following the procedure; their occurrence was significantly associated with obesity (P = .002) but no technical or operative factors. Nineteen patients (15%) sustained serious systemic complications; their occurrence was significantly associated with chronic limb-threatening ischemia (P < .001), and a high American Society of Anesthesiologists (ASA) class (P = .002). By 6 months, 17 patients (13%) had died. Being on dialysis, presenting with chronic limb-threatening ischemia, and being in a high ASA class at the time of operation were all associated with 6-month mortality; a high ASA class at the time of operation was independently predictive of mortality (odds ratio, 3.08; 95% confidence interval, 1.03-9.24; P = .044). CONCLUSIONS: Although commonly performed, CFE is not a benign vascular procedure. Disease presentation, anesthetic risk, and expected longevity play an important role in clinical outcomes. Evolving endovascular approaches to the common femoral artery could serve to reduce morbidity and mortality in the future.
引用
- Chaney M, Joshi G, Serrato JC, et al. Morbidity and mortality of common femoral endarterectomy. J Vasc Surg. 2024. PMID: 38360191. doi:10.1016/j.jvs.2024.01.211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。